226 related articles for article (PubMed ID: 23134100)
1. Drug-drug interactions in the medical intensive care unit: an assessment of frequency, severity and the medications involved.
Smithburger PL; Kane-Gill SL; Seybert AL
Int J Pharm Pract; 2012 Dec; 20(6):402-8. PubMed ID: 23134100
[TBL] [Abstract][Full Text] [Related]
2. Clinically important potential drug-drug interactions in outpatient settings.
Aparasu R; Baer R; Aparasu A
Res Social Adm Pharm; 2007 Dec; 3(4):426-37. PubMed ID: 18082877
[TBL] [Abstract][Full Text] [Related]
3. Drug-drug interactions in cardiac and cardiothoracic intensive care units: an analysis of patients in an academic medical centre in the US.
Smithburger PL; Kane-Gill SL; Seybert AL
Drug Saf; 2010 Oct; 33(10):879-88. PubMed ID: 20812772
[TBL] [Abstract][Full Text] [Related]
4. Grading the severity of drug-drug interactions in the intensive care unit: a comparison between clinician assessment and proprietary database severity rankings.
Smithburger PL; Kane-Gill SL; Benedict NJ; Falcione BA; Seybert AL
Ann Pharmacother; 2010 Nov; 44(11):1718-24. PubMed ID: 20959499
[TBL] [Abstract][Full Text] [Related]
5. Comparison of two databases to detect potential drug-drug interactions between prescriptions of HIV/AIDS patients in critical care.
Ramos GV; Guaraldo L; Japiassú AM; Bozza FA
J Clin Pharm Ther; 2015 Feb; 40(1):63-7. PubMed ID: 25329640
[TBL] [Abstract][Full Text] [Related]
6. Impact of pharmacists' intervention on identification and management of drug-drug interactions in an intensive care setting.
Hasan SS; Lim KN; Anwar M; Sathvik BS; Ahmadi K; Yuan AW; Kamarunnesa MA
Singapore Med J; 2012 Aug; 53(8):526-31. PubMed ID: 22941130
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology and characteristics of adverse drug reactions caused by drug-drug interactions.
Magro L; Moretti U; Leone R
Expert Opin Drug Saf; 2012 Jan; 11(1):83-94. PubMed ID: 22022824
[TBL] [Abstract][Full Text] [Related]
8. Clinically significant drug-drug interactions between oral anticancer agents and nonanticancer agents: profiling and comparison of two drug compendia.
Wong CM; Ko Y; Chan A
Ann Pharmacother; 2008 Dec; 42(12):1737-48. PubMed ID: 19033481
[TBL] [Abstract][Full Text] [Related]
9. Clinically significant drug-drug interactions between oral anticancer agents and nonanticancer agents: a Delphi survey of oncology pharmacists.
Chan A; Tan SH; Wong CM; Yap KY; Ko Y
Clin Ther; 2009; 31 Pt 2():2379-86. PubMed ID: 20110047
[TBL] [Abstract][Full Text] [Related]
10. An evidence-based assessment of the clinical significance of drug-drug interactions between disease-modifying antirheumatic drugs and non-antirheumatic drugs according to rheumatologists and pharmacists.
van Roon EN; van den Bemt PM; Jansen TL; Houtman NM; van de Laar MA; Brouwers JR
Clin Ther; 2009 Aug; 31(8):1737-46. PubMed ID: 19808132
[TBL] [Abstract][Full Text] [Related]
11. Clinical relevance of drug-drug interactions in hospitalized dermatology patients.
Ganeva M; Gancheva T; Troeva J; Kiriyak N; Hristakieva E
Adv Clin Exp Med; 2013; 22(4):555-63. PubMed ID: 23986216
[TBL] [Abstract][Full Text] [Related]
12. [Drug interactions and adverse events induced by drugs used in an intensive care unit].
Plaza J; Alamo M; Torres P; Fuentes A; López F
Rev Med Chil; 2010 Apr; 138(4):452-60. PubMed ID: 20668793
[TBL] [Abstract][Full Text] [Related]
13. Identification of drug interactions in hospitals--computerized screening vs. bedside recording.
Blix HS; Viktil KK; Moger TA; Reikvam A
J Clin Pharm Ther; 2008 Apr; 33(2):131-9. PubMed ID: 18315778
[TBL] [Abstract][Full Text] [Related]
14. Medication errors during medical emergencies in a large, tertiary care, academic medical center.
Gokhman R; Seybert AL; Phrampus P; Darby J; Kane-Gill SL
Resuscitation; 2012 Apr; 83(4):482-7. PubMed ID: 22001000
[TBL] [Abstract][Full Text] [Related]
15. Potential drug-drug interactions in cardiothoracic intensive care unit of a pulmonary teaching hospital.
Farzanegan B; Alehashem M; Bastani M; Baniasadi S
J Clin Pharmacol; 2015 Feb; 55(2):132-6. PubMed ID: 25369984
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and predictors of potential drug-drug interactions in Regione Emilia-Romagna, Italy.
Gagne JJ; Maio V; Rabinowitz C
J Clin Pharm Ther; 2008 Apr; 33(2):141-51. PubMed ID: 18315779
[TBL] [Abstract][Full Text] [Related]
17. Detection and prevention of drug-drug interactions in the hospitalized elderly: utility of new cytochrome p450-based software.
Zakrzewski-Jakubiak H; Doan J; Lamoureux P; Singh D; Turgeon J; Tannenbaum C
Am J Geriatr Pharmacother; 2011 Dec; 9(6):461-70. PubMed ID: 22019006
[TBL] [Abstract][Full Text] [Related]
18. Drug safety alert generation and overriding in a large Dutch university medical centre.
van der Sijs H; Mulder A; van Gelder T; Aarts J; Berg M; Vulto A
Pharmacoepidemiol Drug Saf; 2009 Oct; 18(10):941-7. PubMed ID: 19579216
[TBL] [Abstract][Full Text] [Related]
19. Clinically important drug-drug interactions in primary care.
Dhabali AA; Awang R; Zyoud SH
J Clin Pharm Ther; 2012 Aug; 37(4):426-30. PubMed ID: 22081958
[TBL] [Abstract][Full Text] [Related]
20. Potential drug-drug interactions in a medical intensive care unit of a university hospital.
Gülçebi İdriz Oğlu M; Küçükibrahimoğlu E; Karaalp A; Sarikaya Ö; Demirkapu M; Onat F; Gören MZ
Turk J Med Sci; 2016 Apr; 46(3):812-9. PubMed ID: 27513261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
